[
    "{\"step_by_step_thinking\": \"Nivolumab is a drug used in the treatment of various forms of cancer. According to the documents, it is a PD-1 inhibitor, not a PD-L1 inhibitor. PD-1 and PD-L1 are both proteins that play a role in the immune system's response to cancer cells. Nivolumab works by blocking PD-1, thereby allowing the immune system to better recognize and attack cancer cells.\", \"answer_choice\": \"B. no\"}"
]